English

Optomed ’s financial reporting in 2021

Report this content

Optomed Plc         Stock Exchange Release    27 August 2020 at 9.15, Helsinki

Optomed’s financial reporting in 2021

Optomed Plc will release its Financial Statement Bulletin, Half-Year Financial Report and Interim Reports in 2021 as follows:

  • Financial Statement Bulletin for 1 January – 31 December 2020, 18 February 2021
  • Interim Report for 1 January – 31 March 2021, 6 May 2021
  • Half-Year Financial Report for 1 January – 30 June 2021, 5 August 2021
  • Interim Report for 1 January – 30 September 2021, 4 November 2021

Annual Report 2020, which includes the company’s financial statements, the report of the Board of Directors, the corporate governance statement and the remuneration report, will be published during the week starting on 8 March at the latest.

 

Optomed’s Annual General Meeting is planned to be held on 28 April 2021 in the Helsinki region, Finland. The Board of Directors will convene the meeting separately at a later date.

A shareholder who requests a certain issue belonging to the General Meeting to be included on the agenda of the meeting, is asked to notify the Board of Directors in writing by post Optomed Plc, Yrttipellontie 1, FI-90230 Oulu, Finland no later than 17 January 2021.


Optomed Plc
 

Further enquiries

Lars Lindqvist, CFO, Optomed Plc, lars.lindqvist@optomed.com

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.

Subscribe